Sign in

You're signed outSign in or to get full access.

Maria Elena Giner

Director at Consolidated Water
Board

About Maria Elena Giner

Independent director appointed to CWCO’s board effective October 1, 2025; committee assignments pending. Dr. Giner brings 35+ years in water infrastructure, capital planning, environmental policy, and regulatory strategy, including serving as U.S. Section Commissioner of the International Boundary and Water Commission (IBWC). She holds a Ph.D. in Public Policy (UT Austin), MBA (UT El Paso), BS in Civil Engineering (LMU), and is a registered Professional Engineer in Texas .

Past Roles

OrganizationRoleTenureCommittees/Impact
International Boundary and Water Commission (U.S. Section)U.S. CommissionerAppointed Aug/Sept 2021; listed 2021–2025Oversaw application of boundary/water treaties; operated major cross-border water infrastructure; administered >$1B capital program
Border Environment Cooperation Commission (BECC)General ManagerPrior to 2017Led development/financing of ~$9B environmental infrastructure along U.S.-Mexico border benefiting ~100 communities and >10M residents

External Roles

OrganizationRoleTypeNotes
International Boundary and Water Commission (U.S. Section)U.S. CommissionerFederal agency/State Dept.Second woman and first Latina in the role; infrastructure operations and treaty implementation

Board Governance

  • Board expansion: CWCO increased board size from 8 to 11 and appointed three independent directors, including Dr. Giner, effective Oct 1, 2025; committee assignments for new directors were not yet determined .
  • Independence: CWCO characterized the new appointees as independent directors .
  • Committees (baseline at 2025 proxy): Four standing committees—Compensation, Audit, Nominations & Corporate Governance, Environmental & Social Governance (ESG)—with the following 2024 composition and chairs (pre-appointment). Maria’s assignments TBD .
  • Attendance norms: Board held four meetings in 2024; each director attended ≥75% of board/committee meetings; directors are expected to attend quarterly meetings and AGM .
  • Policies: Code of Business Conduct & Ethics, Insider Trading policy that prohibits hedging/pledging by directors/officers; audit committee oversees cybersecurity risk .
CommitteeChairMembers (2024 baseline; pre-appointment)
CompensationRaymond WhittakerButler, Ebanks, Flowers, Whittaker
AuditLeonard J. SokolowButler, Pergande, Sokolow, Whittaker
Nominations & Corporate GovernanceLinda Beidler‑D’AguilarBeidler‑D’Aguilar, Ebanks, Pergande, Sokolow
Environmental & Social GovernanceFrederick W. McTaggartBeidler‑D’Aguilar, Butler, Flowers, McTaggart

Fixed Compensation (Director Policy)

ComponentAmount (2024 policy)Notes
Annual cash retainer – Chairman$103,000For independent Chairman
Annual cash retainer – Non‑employee director$33,000For each non‑executive director
Compensation Committee cash – Member$3,300Per director
Compensation Committee cash – Chair$5,550Chair premium
Audit Committee cash – Member$4,400Per director
Audit Committee cash – Chair$7,400Chair premium
Nominations & Corporate Governance cash – Member$2,200Per director
Nominations & Corporate Governance cash – Chair$3,700Chair premium
ESG Committee cash – Member$4,400Per director
ESG Committee cash – Chair$7,400Chair premium

The Board determined to increase director compensation described above by 6% for 2025 (exact updated amounts not itemized in the proxy) .

Performance Compensation (Director Equity)

ComponentEquity ValueMechanics
Annual equity retainer – Chairman$32,500Granted in Ordinary Shares under non‑exec director share plan
Annual equity retainer – Non‑employee director$33,150Granted in Ordinary Shares; shares calculated by dividing equity retainer by prevailing market price on Oct 1 of preceding year
Committee equity – Compensation (Member/Chair)$5,835 / $7,485Annual equity retainers in shares
Committee equity – Audit (Member/Chair)$7,780 / $9,980Annual equity retainers in shares
Committee equity – Nominations (Member/Chair)$3,890 / $4,990Annual equity retainers in shares
Committee equity – ESG (Member/Chair)$7,780 / $9,980Annual equity retainers in shares
  • More than 40% of director compensation is comprised of Company stock, reinforcing alignment .

Other Directorships & Interlocks

Company/InstitutionBoard/RoleStatusPotential Interlock/Exposure
IBWC (U.S. Section)U.S. CommissionerOngoing in 2021–2025 timeframeFederal treaty/infrastructure oversight; not a corporate issuer. Note CWCO’s services segment includes U.S. federal O&M contracts, which warrants careful recusals if any matter intersects IBWC to avoid perceived conflicts .

No public company directorships disclosed for Dr. Giner in CWCO filings/press releases .

Expertise & Qualifications

  • Technical and governance expertise: Executive leadership in water infrastructure delivery, capital programs, asset management, environmental policy/regulation; PE (Texas); advanced degrees (PhD/MBA/BS) .
  • Track record: Oversaw >$1B IBWC capital program; previously led BECC’s ~$9B environmental infrastructure financing benefiting ~100 communities and >10M residents .

Equity Ownership

  • Not disclosed: As of the 2025 proxy (record date March 28, 2025), beneficial ownership tables include incumbent directors and officers prior to Oct 2025; Maria Elena Giner was appointed Oct 1, 2025 and is not included in those ownership disclosures .
  • Alignment policies: Directors/officers prohibited from hedging/pledging Company stock; ownership is reinforced via equity retainers .

Governance Assessment

  • Strengths
    • Independence affirmed at appointment; deep, relevant domain expertise in water infrastructure and policy—valuable for CWCO’s desalination, water reuse, and services segments .
    • Board equity-heavy director pay (>40% in stock) and hedging/pledging prohibitions support alignment; strong governance architecture (four committees, independent Chair) .
    • Board engagement norms (≥75% attendance; quarterly cadence) and clear related‑party transaction policy bolster investor confidence .
  • Watch items / potential red flags to monitor
    • Committee assignments for Dr. Giner are not yet determined; investors should watch for Audit/Comp/Nominating placements given her expertise .
    • Concurrent federal role as IBWC Commissioner requires strict recusals on any CWCO matters overlapping U.S. federal water assets or IBWC treaty work to avoid perceived conflicts; CWCO’s related‑party policy and insider trading/ethics frameworks are mitigating structures .
    • Board expanded rapidly from 8 to 11 in Oct 2025; track integration/attendance in 2025–2026 and any shifts in committee leadership .

Say‑on‑Pay & Shareholder Feedback (Context)

  • 2024 advisory vote on executive compensation passed with ~88% support; indicates general shareholder approval of CWCO’s pay practices; not specific to directors but relevant for governance climate .

Notes on CWCO Context

  • CWCO highlighted strengthened governance and expertise with the October 2025 additions (including Dr. Giner) and expects enhanced oversight of capital programs and execution of strategic priorities .
  • CWCO operates globally across desalination and water treatment; current large project cited: $204M design‑build‑operate seawater desalination plant in Hawaii .

Committee assignments for Dr. Giner and any director share ownership disclosures should be updated in CWCO’s next proxy or subsequent 8‑K filings; monitor for Section 16 filings post‑appointment .